Mammoth Biosciences
Mammoth Biosciences is harnessing the diversity of nature to power the next-generation of CRISPR products. Through the discovery and development of novel CRISPR systems, the company is enabling the full potential of its platform to read and write the code of life.
Content by Mammoth Biosciences
|2 min read
Mammoth Biosciences Signs Agreements with MilliporeSigma and Hamilton Company Targeting Commercialization of High-Throughput CRISPR-based SARS CoV-2 Test
The company has signed agreements with MilliporeSigma to scale manufacturing and with Hamilton Company to market a turnkey solution to help CLIA laboratories rapidly add testing capacityPage 1 of 1
